Amy Spallone

507 total citations
37 papers, 291 citations indexed

About

Amy Spallone is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Amy Spallone has authored 37 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 17 papers in Oncology and 14 papers in Infectious Diseases. Recurrent topics in Amy Spallone's work include Cytomegalovirus and herpesvirus research (14 papers), Antifungal resistance and susceptibility (7 papers) and CAR-T cell therapy research (6 papers). Amy Spallone is often cited by papers focused on Cytomegalovirus and herpesvirus research (14 papers), Antifungal resistance and susceptibility (7 papers) and CAR-T cell therapy research (6 papers). Amy Spallone collaborates with scholars based in United States, Switzerland and Mexico. Amy Spallone's co-authors include Robert L. Atmar, Hana M. El Sahly, Maria C. Rodriguez‐Barradas, Prathit A. Kulkarni, Ilan S. Schwartz, Roy F. Chemaly, Fareed Khawaja, Camille N. Kotton, Ella Ariza‐Heredia and Dimitrios P. Kontoyiannis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Microbiology and Infection.

In The Last Decade

Amy Spallone

32 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Spallone United States 9 140 111 96 61 45 37 291
Emily M. Whettlock United Kingdom 5 96 0.7× 159 1.4× 41 0.4× 21 0.3× 40 0.9× 7 362
Jacob K. Files United States 7 168 1.2× 129 1.2× 33 0.3× 30 0.5× 38 0.8× 12 354
Jason Gummow Australia 9 177 1.3× 120 1.1× 102 1.1× 17 0.3× 30 0.7× 10 373
Georg Beythien Germany 7 153 1.1× 110 1.0× 60 0.6× 25 0.4× 15 0.3× 14 302
Desiree Redmond Canada 9 158 1.1× 70 0.6× 27 0.3× 18 0.3× 24 0.5× 14 403
Eleanor Y. Lim United Kingdom 9 55 0.4× 65 0.6× 138 1.4× 24 0.4× 34 0.8× 13 268
Jun-Sun Park South Korea 8 249 1.8× 140 1.3× 34 0.4× 14 0.2× 23 0.5× 22 371
Sarah Sterrett United States 11 181 1.3× 94 0.8× 86 0.9× 15 0.2× 33 0.7× 15 355
Evan S. Bradley United States 7 61 0.4× 47 0.4× 38 0.4× 25 0.4× 10 0.2× 14 445
Hilary Staples United States 7 153 1.1× 43 0.4× 31 0.3× 20 0.3× 12 0.3× 9 262

Countries citing papers authored by Amy Spallone

Since Specialization
Citations

This map shows the geographic impact of Amy Spallone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Spallone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Spallone more than expected).

Fields of papers citing papers by Amy Spallone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Spallone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Spallone. The network helps show where Amy Spallone may publish in the future.

Co-authorship network of co-authors of Amy Spallone

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Spallone. A scholar is included among the top collaborators of Amy Spallone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Spallone. Amy Spallone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yaghi, Layale, Roy F. Chemaly, William C. Shropshire, et al.. (2025). The efficacy of a filtered handheld far-ultraviolet disinfection device for decontamination of high-touch surfaces in healthcare settings: a genomic bacterial analysis. Infection Control and Hospital Epidemiology. 46(10). 1027–1034. 1 indexed citations
3.
Daher, Marilyne, Fareed Khawaja, Amy Spallone, et al.. (2025). Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients. Transplant Infectious Disease. 27(2). e14444–e14444. 2 indexed citations
4.
Chemaly, Roy F., Ying Jiang, Jeremy Ramdial, et al.. (2025). P-1013. Incidence and Risk Factors for Fungal Infection after CD19-targeted Chimeric Antigen Receptor T cell Therapy for Non-Hodgkin Lymphoma. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
5.
Feldman, Adina L., et al.. (2024). Prevalence of Candida auris Among High-Risk Patients at a Comprehensive Cancer Center. SHILAP Revista de lepidopterología. 4(S1). s91–s92. 1 indexed citations
6.
Shropshire, William C., Micah M. Bhatti, Awdhesh Kalia, et al.. (2024). Rapid whole genome characterization of antimicrobial-resistant pathogens using long-read sequencing to identify potential healthcare transmission. Infection Control and Hospital Epidemiology. 46(2). 129–135. 2 indexed citations
7.
Khawaja, Fareed, Sairah Ahmed, Swaminathan P. Iyer, et al.. (2024). Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes. Open Forum Infectious Diseases. 11(8). 63–64. 11 indexed citations
8.
Khawaja, Fareed, Terri Lynn Shigle, Gabriela Rondón, et al.. (2024). Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience. Clinical Microbiology and Infection. 30(6). 803–809. 8 indexed citations
9.
Khawaja, Fareed, Adina L. Feldman, Vinod Ravi, et al.. (2023). COVID‐19 in cancer patients: The impact of vaccination on outcomes early in the pandemic. Cancer Medicine. 12(24). 22006–22022. 5 indexed citations
10.
Ford, Emily S., Genovefa A. Papanicolaou, Sanjeet Dadwal, Steven A. Pergam, & Amy Spallone. (2023). Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy. Transplantation and Cellular Therapy. 29(5). 289–292. 2 indexed citations
11.
Khawaja, Fareed, Amy Spallone, Terri Lynn Shigle, et al.. (2023). 1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
12.
Spallone, Amy, et al.. (2023). The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center. American Journal of Infection Control. 51(12). 1302–1308. 8 indexed citations
13.
Khawaja, Fareed, Joseph Sassine, Swaminathan P. Iyer, et al.. (2022). Herpesviruses Infections in CAR T Cell Recipients. Transplantation and Cellular Therapy. 28(3). S381–S382. 3 indexed citations
14.
Khawaja, Fareed, Amy Spallone, Adina L. Feldman, et al.. (2022). Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned. American Journal of Infection Control. 51(5). 506–513. 1 indexed citations
15.
Khawaja, Fareed, Amy Spallone, Camille N. Kotton, & Roy F. Chemaly. (2022). Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium. Clinical Microbiology and Infection. 29(1). 44–50. 28 indexed citations
16.
Sassine, Joseph, Fareed Khawaja, Adam J. DiPippo, et al.. (2021). 930. Clinically Significant CMV Infections in Patients with Lymphoma or Multiple Myeloma. Open Forum Infectious Diseases. 8(Supplement_1). S557–S558. 2 indexed citations
17.
Spallone, Amy & Ilan S. Schwartz. (2021). Emerging Fungal Infections. Infectious Disease Clinics of North America. 35(2). 261–277. 31 indexed citations
18.
Spallone, Amy, Ahmad S. Alotaibi, Ying Jiang, Naval Daver, & Dimitrios P. Kontoyiannis. (2021). Infectious Complications Among Patients With AML Treated With Immune Checkpoint Inhibitors. Clinical Lymphoma Myeloma & Leukemia. 22(5). 305–310. 3 indexed citations
19.
Spallone, Amy, et al.. (2020). Histoplasmosis in Liver Transplant Recipients: Case Reports and a Review of the Literature. 4(1). 1–17. 4 indexed citations
20.
Malek, Alexandre, et al.. (2019). Necrotizing soft tissue invasive aspergillosis in a cancer patient treated with immunosupressants due to checkpoint inhibitor-induced hepatitis. Journal of Infection. 80(2). 232–254. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026